Urologic Cancers
FEATURED CONTENT
-
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
-
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Lynch syndrome.
-
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
-
The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
-
Investigators found that men receiving androgen deprivation therapy for prostate cancer had a 1% rate of major adverse cardiovascular events.
UROLOGIC CANCERS NEWS
Next post in Urologic Cancers
Loading...
Loading...